🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Minnesota › Rochester

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Rochester, MN keessatti

Qorannoo 12 Leukemia Myeloidii Hamaa f Rochester fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Mayo Clinic in Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Mayo Clinic in Rochester, Rochester
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Mayo Clinic in Rochester, Rochester
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Namoota walitti qabaa jiraSadarkaa 1/2
  • Mayo Clinic, Rochester
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT04588922

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Namoota walitti qabaa jiraSadarkaa 3
  • US-Rochester MN-MAYOMN, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06652438

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic in Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT03017820

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1/2
  • Mayo Clinic Comprehensive Cancer Center, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT05732103

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Mayo Clinic in Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Elb-2026 · NCT06279572

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic - Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Gur-2026 · NCT06950034

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Mayo Clinic, Rochester
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Ado-2025 · NCT05237258

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Rochester keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.